MedTrace Logo

Covid-19 Pandemic: Patients' Experience in T1D

NCT04384471 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 384

Last updated 2021-02-24

No results posted yet for this study

Summary

Given the current situation with COVID-19 declared pandemic on March 11, 2020 and the requirement for physical distancing and to limit social interactions, and for some, to quarantine, the investigators will survey patients living with type 1 diabetes (and their families, if they are \<18 years) about their current experience with their diabetes management to understand their needs.

The primary objective is to describe the exposition and the impact of COVID-19 pandemic on type 1 diabetes. The investigators will recruit people with type 1 diabetes from all ages living in Quebec to answer a short online survey.

Conditions

  • Type1diabetes
  • Covid19

Interventions

OTHER

Online survey

Participants are invited to answer an online questionnaire including both close-ended and open-ended questions about their experience during this sanitary crisis

Sponsors & Collaborators

  • Juvenile Diabetes Research Foundation

    collaborator OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • McGill University

    lead OTHER

Principal Investigators

  • Anne-Sophie Brazeau, PhD · McGill University

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-29
Primary Completion
2020-07-01
Completion
2020-07-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04384471 on ClinicalTrials.gov